FIRST IN HUMAN STUDIES

The staff and investigator at Clinical Pharmacology of Miami have extensive experience with designing and implementing “First in Man” studies. This is one of the most critical steps in the entire drug development process. Competence at this point is important so that a potential blockbuster drug that can save lives and prevent suffering will not be erroneously discarded and that a potentially unsafe drug is not continued in the research pipeline needlessly costing millions of dollars and exposing countless research subjects to unnecessary risk. Clinical Pharmacology of Miami can help you avoid these pitfalls by helping design and implement your study according to sound scientific principles.

Guidance for Industry:
Estimating the Maximum Safe Starting Doses in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers
2005 US Food and Drug Administration

DOWNLOAD


  
   POPULATIONS     > > > >


HEALTHY MALE & FEMALES 


HEPATICALLY IMPAIRED
 

RENALLY IMPAIRED
 

HYPERTENSIVE
 

GERIATRIC
 

DIABETIC
 

OBESE
 

  SPECIALTIES     > > > >

ADME 

FIRST IN HUMAN 

CARDIAC SAFETY 

  INFORMATION     > > > >

REPRINTS
 
   
   

 

©2008 CLINICAL PHARMACOLOGY OF MIAMI, Inc